| Course Unit Code | Course Unit Title | Type of Course Unit | Year of Study | Semester | Number of ECTS Credits | | HM203B | | Compulsory | 2 | 3 | 3 |
|
| Level of Course Unit |
| First Cycle |
| Objectives of the Course |
| To learn the pharmacokinetics of drugs, drug action mechanisms, drug interactions, drug use, contraindications and side effects. |
| Name of Lecturer(s) |
| Dr. Öğretim Üyesi Zila Özlem KIRBAŞ |
| Learning Outcomes |
| 1 | To be able to describe the effects of the body on drugs used in various ways | | 2 | To be able to describe the mechanisms of action, interactions, side effects and contraindications of drugs used in the treatment of diseases related to all body systems | | 3 | To be able to describe the methods used to prevent pregnancy, the mechanisms of action, interactions, side effects and contraindications of birth control drugs | | 4 | Being aware of the adverse effects of currently used drugs | | 5 | To be able to express the necessity and importance of notifying the relevant centers in the Ministry of Health when adverse drug effects occur |
|
| Mode of Delivery |
| Normal Education |
| Prerequisites and co-requisities |
| None |
| Recommended Optional Programme Components |
| None |
| Course Contents |
| This lesson; Includes Introduction to Pharmacology, Pharmacokinetics, Pharmacovigilance, Autonomic Nervous System, Central Nervous System, Cardiovascular System, Respiratory System, Gastrointestinal System and Urinary System Pharmacology, Chemotherapeutics, NSAII and Other Anti-Inflammatory Drugs, Birth Control Drugs. |
| Weekly Detailed Course Contents |
|
| 1 | Introduction to pharmacology | None | None | | 2 | Mechanism of Action of Drugs and Drug-Receptor Relationship | None | None | | 3 | Pharmacokinetics | None | None | | 4 | Autonomic Nervous System - Sympathetic System | None | None | | 5 | Autonomic Nervous System -Cholinomimetics | None | None | | 6 | Cardiovascular System Drugs | None | None | | 7 | Cardiovascular System Drugs | None | None | | 8 | Midterm | None | None | | 9 | Cardiovascular System Drugs | None | None | | 10 | Pharmacovigilance | None | None | | 11 | Respiratory System Medications | None | None | | 12 | GIS Drugs | None | None | | 13 | Renal System Drugs | None | None | | 14 | Drugs used in water-electrolyte balance disorder and drugs used in acid-base balance disorder | None | None | | 15 | Central Nervous System Drugs | None | None |
|
| Recommended or Required Reading |
| Katzung B.G. (2018) Basic & Clinical Pharmacology, 14 th Edition, McGraw Hill Medical Books.
Brunton L.L., Hilal-Dandan R., Knollmann B.C. (2018) Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13 th Edition, Mcgraw Hill Medical Books.
Kayaalp O. Akılcı Tedavi Yönünden Tıbbi Farmakoloji 1-2, 13. Baskı, Pelikan Kitabevi, 2018.
Goodman L.S., Gilman A.G., Rall T.W. and Murad F. (1985) The Pharmacological Basis of Therapeutics, Blackwell Scientific Publications, Oxford, England. |
| Planned Learning Activities and Teaching Methods |
|
| Assessment Methods and Criteria | |
| Midterm Examination | 1 | 100 | | SUM | 100 | |
| Final Examination | 1 | 100 | | SUM | 100 | | Term (or Year) Learning Activities | 40 | | End Of Term (or Year) Learning Activities | 60 | | SUM | 100 |
| | Language of Instruction | | Turkish | | Work Placement(s) | | None |
|
| Workload Calculation |
|
| Midterm Examination | 1 | 1 | 1 |
| Final Examination | 1 | 1 | 1 |
| Attending Lectures | 28 | 1 | 28 |
| Question-Answer | 5 | 1 | 5 |
| Self Study | 14 | 1 | 14 |
| Individual Study for Mid term Examination | 7 | 1 | 7 |
| Individual Study for Final Examination | 14 | 1 | 14 |
| Reading | 5 | 1 | 5 |
| Homework | 10 | 1 | 10 |
|
| Contribution of Learning Outcomes to Programme Outcomes |
| LO1 | 5 | 3 | 3 | 3 | 4 | 3 | 4 | 4 | 4 | 3 | 1 | 4 | 4 | 3 | 3 | | LO2 | 5 | 3 | 4 | 3 | 4 | 3 | 4 | 4 | 4 | 3 | 1 | 4 | 4 | 3 | 3 | | LO3 | 5 | 3 | 4 | 3 | 4 | 3 | 4 | 4 | 4 | 3 | 1 | 4 | 4 | 3 | 3 | | LO4 | 5 | 3 | 4 | 3 | 4 | 3 | 4 | 4 | 4 | 3 | 1 | 4 | 4 | 3 | 3 | | LO5 | 5 | 3 | 3 | 3 | 4 | 3 | 4 | 4 | 4 | 3 | 1 | 4 | 4 | 3 | 3 |
|
| * Contribution Level : 1 Very low 2 Low 3 Medium 4 High 5 Very High |
 |
| |